Quinsam Capital (QCA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jun, 2026Executive summary
Reported a Q4 2024 net loss of $4.3 million ($0.04 per share), compared to a net loss of $1.6 million ($0.02 per share) in Q4 2023.
Losses driven by a decline in California Nanotechnologies share price and provisions in the private securities portfolio.
Net assets at December 31, 2024, were approximately $0.10 per share, with liquid investments totaling about $0.05 per share.
Financial highlights
Q4 2024 net loss of $4.3 million, up from $1.6 million loss in Q4 2023.
Basic and fully diluted loss per share was $0.04, compared to $0.02 in the prior year quarter.
Outlook and guidance
Anticipates further realizations on the Guelph mortgage asset, though timing and amounts remain uncertain.
Expects progress in private portfolio companies, with several aiming for public listings in 2025.
Continues to seek value-creating transactions, noting a slow market for new listings.
Latest events from Quinsam Capital
- Q2 net loss narrowed, liquidity improved, and several IPOs are pending amid a cautious outlook.QCA
Q2 202510 Jun 2026 - Q4 outlook hinges on public listings and clinical milestones, with NAV poised for potential growth.QCA
Q3 202510 Jun 2026 - Q1 2025 net income fell to $0.2M; several private holdings near listing, shares below NAV.QCA
Q1 20259 Jun 2026 - Q3 profit surged to $1.2M on Cal Nano gains, Givex privatization, and cost cuts.QCA
Q3 20249 Jun 2026 - Q2 net loss improved, new investments made, and share repurchases continue amid strategic review.QCA
Q2 20249 Jun 2026 - Q1 net income and NAV surged, with mining gains and a major listing expected to drive growth.QCA
Q1 202620 May 2026 - Q4/2025 profit and NAV growth driven by strong investments; further gains expected in Q1/2026.QCA
Q4 202528 Apr 2026